Your session is about to expire
← Back to Search
Impact of Integrated Care Pathways for Prevention of Post-operative Urinary Retention (POUR) (POUR Trial)
N/A
Waitlist Available
Led By Mark Snyder, MD
Research Sponsored by TriHealth Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 hours post-op
Awards & highlights
No Placebo-Only Group
Summary
A prospective randomized control trial will be conducted at Good Samaritan Hospital and TriHealth Evendale Hospital. Subjects will receive total hip or knee surgery and follow-up via standard care at the discretion of the treating physician or the experimental study arm in which all patients will undergo the integrated care pathway.
Eligible Conditions
- Urinary Retention
- Hip Replacement
- Knee Replacement Surgery
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 24 hours post-op
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 hours post-op
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
POUR
Secondary study objectives
opioid consumption
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
Patient will complete IPSS score, medical history, and risk factors for POUR will be evaluated. If considered high risk (determined by IPSS), then patient Patient will undergo integrated care pathway that avoids narcotics. Bladder volume will be measured in PACU, after admission to the nursing unit, and prior to discharge from the hospital (post-void).
Group II: ControlExperimental Treatment1 Intervention
Patient will complete IPSS score, medical history, and risk factors for POUR will be evaluated. Patient will undergo treating physician's standard of care for total hip or knee replacement. Patient will receive bladder scans in PACU, upon admission to the nursing unit, and prior to discharge (post-void).
Find a Location
Who is running the clinical trial?
TriHealth Inc.Lead Sponsor
99 Previous Clinical Trials
53,659 Total Patients Enrolled
3 Trials studying Urinary Retention
443 Patients Enrolled for Urinary Retention
Mark Snyder, MDPrincipal Investigator - TriHealth Inc.
The Jewish Hospital - Mercy Health, TriHealth Orthopedic & Sports Institute
University Of Cincinnati College Of Medicine (Medical School)
University Hosp, Inc (Residency)
2 Previous Clinical Trials
82 Total Patients Enrolled